Physician
Retinovitreous Associates LTD
Retinovitreous Associates LTD was paid $508K by Medicaid between Jan 2018 and Nov 2024, across 10 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 42% of everything it billed.
33Billing provider infoRETINOVITREOUS ASSOCIATES LTD
WILMINGTON, DE 19803
WILMINGTON, DE 19803
33aNPI1952552630assigned 10/01/2008
33bProvider typeRetina Specialist (Ophthalmology) Physician
28Total paid$508K
24GClaims7,313
24DCodes billed10
24AFirst – last monthJan 2018 – Nov 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 163 | $279.52 | |
| 2019 | 789 | $8K | |
| 2020 | 586 | $18K | |
| 2021 | 1,449 | $63K | |
| 2022 | 1,641 | $130K | |
| 2023 | 1,798 | $221K | |
| 2024incomplete | 887 | $69K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 42% | 201 | 155 | $214K |
| 67028 | Intravitreal injection of a pharmacologic agent | 20% | 2,033 | 1,561 | $101K |
| J2778 | Injection, ranibizumab, 0.1 mg | 20% | 222 | 150 | $101K |
| 92134 | 9.5% | 3,200 | 2,516 | $48K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 6.9% | 1,389 | 1,092 | $35K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 102 | 95 | $4K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 47 | 38 | $1K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 31 | 24 | $1K |
| 92201 | <1% | 72 | 54 | $852.97 | |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 16 | 13 | $813.08 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHEPPARD, COURTNEY (CAO/CFO)
| Provider | Location | Paid |
|---|---|---|
| Retinovitreous Associates LTD | Plymouth Meeting, PA | $5.10M |
| Associated Retinal Surgeons, PA | Cherry Hill, NJ | $2.58M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.